Structural basis for activation of the growth hormone-releasing hormone receptor.
Binding Sites
Cryoelectron Microscopy
Dwarfism, Pituitary
/ genetics
GTP-Binding Proteins
Growth Hormone-Releasing Hormone
/ chemistry
Humans
Molecular Dynamics Simulation
Mutagenesis
Mutation
Protein Conformation
Protein Conformation, alpha-Helical
Receptors, Neuropeptide
/ chemistry
Receptors, Pituitary Hormone-Regulating Hormone
/ chemistry
Signal Transduction
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
15 10 2020
15 10 2020
Historique:
received:
04
06
2020
accepted:
14
09
2020
entrez:
16
10
2020
pubmed:
17
10
2020
medline:
3
11
2020
Statut:
epublish
Résumé
Growth hormone-releasing hormone (GHRH) regulates the secretion of growth hormone that virtually controls metabolism and growth of every tissue through its binding to the cognate receptor (GHRHR). Malfunction in GHRHR signaling is associated with abnormal growth, making GHRHR an attractive therapeutic target against dwarfism (e.g., isolated growth hormone deficiency, IGHD), gigantism, lipodystrophy and certain cancers. Here, we report the cryo-electron microscopy (cryo-EM) structure of the human GHRHR bound to its endogenous ligand and the stimulatory G protein at 2.6 Å. This high-resolution structure reveals a characteristic hormone recognition pattern of GHRH by GHRHR, where the α-helical GHRH forms an extensive and continuous network of interactions involving all the extracellular loops (ECLs), all the transmembrane (TM) helices except TM4, and the extracellular domain (ECD) of GHRHR, especially the N-terminus of GHRH that engages a broad set of specific interactions with the receptor. Mutagenesis and molecular dynamics (MD) simulations uncover detailed mechanisms by which IGHD-causing mutations lead to the impairment of GHRHR function. Our findings provide insights into the molecular basis of peptide recognition and receptor activation, thereby facilitating the development of structure-based drug discovery and precision medicine.
Identifiants
pubmed: 33060564
doi: 10.1038/s41467-020-18945-0
pii: 10.1038/s41467-020-18945-0
pmc: PMC7567103
doi:
Substances chimiques
Receptors, Neuropeptide
0
Receptors, Pituitary Hormone-Regulating Hormone
0
Growth Hormone-Releasing Hormone
9034-39-3
GTP-Binding Proteins
EC 3.6.1.-
somatotropin releasing hormone receptor
F8L0ODC9D7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5205Références
Nature. 2018 Sep;561(7724):492-497
pubmed: 30209400
Nature. 2011 Jul 19;477(7366):549-55
pubmed: 21772288
J Chem Theory Comput. 2008 Jan;4(1):116-22
pubmed: 26619985
Phys Rev A. 1992 Nov 15;46(10):6541-6549
pubmed: 9907963
J Struct Biol. 2018 Oct;204(1):90-95
pubmed: 29981840
J Biol Chem. 2016 Jul 15;291(29):15119-30
pubmed: 27226600
Mol Cell. 2020 Feb 6;77(3):669-680.e4
pubmed: 32004470
Nature. 2017 Jun 8;546(7657):312-315
pubmed: 28514449
Science. 2019 Apr 12;364(6436):148-153
pubmed: 30975883
Hum Mutat. 2019 Nov;40(11):2033-2043
pubmed: 31231873
J Endocrinol Invest. 2016 Jul;39(7):721-7
pubmed: 26891937
Science. 1982 Nov 5;218(4572):585-7
pubmed: 6812220
Nat Commun. 2020 Aug 17;11(1):4121
pubmed: 32807782
Nature. 2018 Jul;559(7712):45-53
pubmed: 29973731
Methods Enzymol. 2016;579:125-57
pubmed: 27572726
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Pituitary. 2007;10(4):351-7
pubmed: 17965963
Mol Biosyst. 2017 Jun 27;13(7):1313-1322
pubmed: 28561845
Nature. 2013 Jul 25;499(7459):444-9
pubmed: 23863937
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2226-2231
pubmed: 30659154
Nature. 2018 Mar 1;555(7694):121-125
pubmed: 29466332
J Med Chem. 1998 Feb 26;41(5):717-27
pubmed: 9513600
ACS Pharmacol Transl Sci. 2020 Mar 20;3(2):263-284
pubmed: 32296767
Nature. 2017 Jun 1;546(7656):118-123
pubmed: 28437792
J Hered. 1976 Mar-Apr;67(2):87-91
pubmed: 1270792
Nature. 1993 Jul 15;364(6434):208-13
pubmed: 8391647
F1000Res. 2016 Feb 18;5:189
pubmed: 26973785
ACS Chem Biol. 2016 Feb 19;11(2):400-8
pubmed: 26569370
Front Endocrinol (Lausanne). 2016 Oct 10;7:129
pubmed: 27777568
Mol Cell. 2020 Feb 6;77(3):656-668.e5
pubmed: 32004469
Nature. 2018 Jan 3;553(7686):106-110
pubmed: 29300013
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Endocr Dev. 2013;24:106-17
pubmed: 23392099
J Vis Exp. 2011 Dec 22;(58):
pubmed: 22215030
Science. 1984 Jul 20;225(4659):326-8
pubmed: 6204379
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Acta Pharmacol Sin. 2012 Mar;33(3):300-11
pubmed: 22266723
Vitam Horm. 2004;69:209-20
pubmed: 15196883
Nature. 2017 Jun 8;546(7657):248-253
pubmed: 28538729
Nat Clin Pract Endocrinol Metab. 2008 Jan;4(1):33-43
pubmed: 18084344
Cell. 2016 Jun 16;165(7):1632-1643
pubmed: 27315480
J Chem Theory Comput. 2011 Oct 11;7(10):3162-3180
pubmed: 22125473
Trends Pharmacol Sci. 2015 Jan;36(1):22-31
pubmed: 25541108
J Clin Invest. 1999 Oct;104(8):1123-30
pubmed: 10525051
Circ Res. 2018 May 11;122(10):1395-1408
pubmed: 29618597
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5211-6
pubmed: 23479653
Peptides. 2014 Feb;52:104-12
pubmed: 24373935
ACS Pharmacol Transl Sci. 2018 Jul 26;1(1):12-20
pubmed: 32219201
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
J Comput Chem. 2014 Oct 15;35(27):1997-2004
pubmed: 25130509
Trends Pharmacol Sci. 2014 Jan;35(1):12-22
pubmed: 24359917
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Science. 2020 Mar 20;367(6484):1346-1352
pubmed: 32193322